C&T Round Up for September 2024!

Issue 283 | September 27, 2024
6 min read
Capsid and Tail

This month we heard about how Sartorius’ columns can bring down endotoxins close to zero. There’s also a new phage data resource called Phage Base! Lastly, we also picked a couple of super interesting papers this month — one about how antibiotics damage the mucus barrier, and another about how Pf phage messes with airway cells.

Sponsor

Podovirus Podcast interview with Dr. Jesus Fernandez on Eligo Bioscience's microbiome editing technology using phages!

🎙️ New Podovirus Podcast Episode Alert!

I had such a great time talking to Jesus Fernandez-Rodriguez, PhD, VP of Technology at Eligo Bioscience, about how they’re editing live microbes in the mouse gut with engineered phages!

🧬 Highlights & questions:

  • 93% editing efficiency in gut E. coli with a single dose of a phage-derived base editor! (And it lasts for at least 6 weeks…!)
  • Where are we at with microbiome therapeutics?
  • How do you make phages deliver genes to live microbes?
  • Is this tool just as cool as a perturbing device (to ASK questions about what happens when you turn off a bacterial gene in the gut) as it is a therapeutic?

Check out the full episode here:
🎧Spotify
📺 Youtube

📄 Here’s the team’s new Nature paper

🤔One thing I really wanted to know, but must remain a secret for a bit longer — what should we be targeting first with something like this?

Would love to hear your thoughts!

What’s New

The second UN General Assembly High-Level Meeting on Antimicrobial Resistance  convened yesterday to address the urgent global health crisis of AMR and its implications for public health, particularly in low- and middle-income countries.

AMRMeetingUN

A 75-year-old female patient with recurrent Pseudomonas septicaemia and arterial stents was treated using a phage–meropenem combination therapy at Tampere University Hospital, Finland. A 3-phage P. aeruginosa cocktail was given IV together with meropenem for 2 weeks. 10-month follow-up showed no adverse reactions, infection markers normalized, recovery was seen in a PET-CT scan, and no further P. aeruginosa septicaemias occurred.

Case reportPhage therapyIntravenous

For OMKO1 and LPS-5, two lytic phages used in Felix Biotech’s CF trial recently, Dea M. Müller and colleagues show that determinants of their host range in P. aeruginosa are bacterial receptors, rather than anti-phage defence mechanisms.

PreprintPhage host range

Peiying Ho and colleagues from the Singapore-MIT Alliance for Research and Technology screened the PA14NR transposon mutant library and identified key genes involved in P. aeruginosa phage resistance. They found 78 mutants capable of thriving in the presence of phages, with 23 carrying insertions in membrane composition genes, and 6 exhibiting total phage resistance.

Research paperTransposon mutagenesisPhage resistance

A novel phage, TS33, targeting Hafnia species in a model Brie-like cheese community; many host factors that contribute to infectivity are O-antigen genes.

Research paperCheesePhage-host interactions

Latest Jobs

PostdocDNA packaging
CNRS, France is hiring a postdoc to study mechanisms of selective phage DNA packaging and bacterial DNA transduction in Bacillus subtilis.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

In a recent interview, Dr. Evelien Adriaenssens (Quadram Institute) discusses her career journey to becoming a Group Leader, focusing on the role of phages in the gut microbiome to promote health and combat disease. She reflects on the diverse responsibilities of managing a research group, including mentoring, formulating new research ideas, and fostering collaborations. She also shares insights on her ongoing phage therapy research, specifically targeting Pseudomonas aeruginosa in patients with chronic lung infections.

InterviewCareerFaculty

David Harper discusses the complexities and limitations of using phages as therapeutics in his recent LinkedIn post, emphasizing the challenges posed by the immune system and the size of phages compared to conventional antibiotics.

OpinionPhage-immune interactions

C&T Round Up for September 2024!

Profile Image
Product designer and co-founder of Phage Directory
Co-founderProduct Designer
Twitter @yawnxyz
Skills

Bioinformatics, Data Science, UX Design, Full-stack Engineering

I am a co-founder of Phage Directory, and have a Master of Human-Computer Interaction degree from Carnegie Mellon University and a computer science and psychology background from UMBC.

For Phage Directory, I design and build tools, and help write and organize Capsid & Tail.

I’ve previously worked at the Westmead Institute, for the Iredell lab at Phage Australia. There, I helped connect bioinformatics outputs and databases like REDCap, Google Drive, and S3-compatible storage systems.

Currently, I’m building and designing AI-centric tools for biology, including experimenting with protein models, biobank databases, AI-supported schema and data parsing, and bioinformatics workflows. Hit me up at [email protected] if you’re curious to collaborate!

Hey all,

Both Jess and I have been hard at work — heads down, thumbs up — in the last month.

Jess has been giving her lab’s phages a *Richard Simmons treatment,* getting them shaped up for compassionate use. She’s also been on a mean streak, recording podcast interviews with people doing cool phage projects. Find her on Spotify!

Meanwhile, I’ve been building out the next system that underpins Phage Directory, which adds a proper profile system, better search, and lets lab create their own lab websites, where they can share their own phage and other biobank data! There’s still a lot of work left to do though, but I’m about 80% there! The goal is to get it shipped before the end of the year.

Lots of exciting stuff (and changes) coming in the fall!

~ Jan & Jessica

Using monolith chromatography to purify phages

by Ažbe Žnidaršič, Lucija Rebula

This article by Ažbe Žnidaršič and Lucija Rebula from Sartorius examines the use of CIMmultus monolithic chromatography for purifying phages. The authors explain how this technique addresses challenges in phage production, such as separating phages from bacterial cell debris and reducing endotoxin levels. CIMmultus columns, made from methacrylate-based materials, offer advantages like laminar flow to protect viral particles, high flow rates, low backpressure, and reusability. For human therapy applications, Znidarsic and Rebula recommend a two-step process: first using a hydroxy (OH) ligand column to remove host cell impurities, followed by a weak anion exchange column (PrimaS) for endotoxin removal. This method maintains high phage infectivity while reducing impurities. The authors note that despite initial investment challenges, CIMmultus monolithic chromatography provides long-term benefits in both research and industrial phage purification applications, offering efficiency, scalability, and versatility.

Our Phage Picks for September 2024!

by Jan Zheng

In September’s Phage Picks, I really got to nerd out: I shared a a study on filamentous Pseudomonas bacteriophage Pf and how it messes with the mucociliary transport in airway cells; shared an article on how antibiotics damage the mucus barrier, and talked about the massive deluge of new AI tools coming down the pike — from a new foundation model for molecular structure prediction, to a slew of tools like NotebookLM and OpenAI’s new o1-series of models. We should really start running a series on how to use these tools (hint: don’t use them for writing; they’re terrible at it).

PhageBase: A visual atlas of phages

by Aaryan Harshith

In this post, Aaryan describes his project PhageBase, an online atlas of phage TEM images and data. He talks about how he got started, and how he’s been able to amass a dataset on over 1000 phages across 150+ bacterial hosts. Their eventual goal is to expand their dataset to over 10,000 phages, develop an API, and add more collaboration features — with the help and collaboration of the phage It emphasizes PhageBase’s role in centralizing phage data and fostering community growth. This is a really cool project in a similar vein as Phage Directory — and they’re looking for contributors!

C&T Throwback!

Behind the curtains, we’ve been thinking hard about biobanks, digitally tracking and sharing phage and bacteria data, and how to tie it together in a simple to use system. This work has been in the works for a loooong time, but things are finally gelling. We’ll have something great to share very soon — including a complete re-haul of the Phage Directory website, new Profile system, Capsid & Tail, and way better search. The building blocks are clicking into place!

In the meantime I’ve been looking over our past articles like how the NCTC re-launches its phage collection, and our old articles on Phage Directory itself, like — Phage Directory expands! What’s changing and what’s staying the same.

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge